Rutgers Cancer Institute of New Jersey's Annual Oncology Clinical Practice and Research Summit | Conference

Dr Phillips on the Shifting Treatment Paradigm For CAR T-Cell Therapy in LBCL

November 28th 2023

Adrienne Phillips, MD, MPH, discusses the impact of CAR T-cell therapy on the treatment paradigm for patients with large B-cell lymphoma, highlighting key advancements in the decision-making process for CAR T-cell therapy selection.

Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care

November 27th 2023

Shridar Ganesan, MD, PhD, discusses the current limitations and advantages of leveraging circulating-tumor DNA to detect minimal residual disease in patients with cancer, as well as how ctDNA assays may address mechanisms of resistance in clinical practice.

Dr Habib on Developments in Palliative Care For Patients With Cancer

November 27th 2023

M. Hamza Habib, MD, JD, MBA, FACP, FAAHPM, FRCPI, MRCP, discusses the development of novel technology-based strategies to improve palliative cancer for patients with cancer.

Rutgers Research Summit Aims to Broaden Oncologic Perspectives Across New Jersey

November 24th 2023

Andrew Evens, DO, MBA, MSc, highlights key points presented during the 2023 Rutgers Cancer Institute of New Jersey’s Annual Oncology Clinical Practice and Research Summit, the clinical implications of these presentations, and lymphoma treatment innovations that Rutgers Cancer Institute is providing to patients throughout New Jersey.

Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC

November 22nd 2023

Patrick Boland, MD, discusses the development of therapeutic strategies targeting KRAS G12C mutations in colorectal cancer.

Dr Phillips on the Management of Toxicities Associated With CAR T-Cell Therapy

November 21st 2023

Adrienne Phillips, MD, MPH, discusses the management of toxicities associated with CAR T-cell therapy across hematologic malignancies.

Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations

November 21st 2023

Haejin In, MD, MPH, MBA, FACS, FSSO, discusses the increased incidence of gastric cancer in minority patient populations, highlighting the disparities that lead to these patient outcomes in the United States.

Dr Ecker on the Investigation of the Microbiome in Pancreatic Cancer

November 17th 2023

Brett L. Ecker, MD, discusses the evaluation of the microbiome in pancreatic cancer, highlighting remaining questions and future steps for research.

Dr Hochster on the Importance of Clinical Trial Participation in Cancer Care

November 14th 2023

Howard S. Hochster, MD, discusses the importance of clinical trial participation for patients with cancer and highlights the use of precision medicine across the treatment armamentarium.

Dr Lazzaro on Lung Cancer Screening in High-Risk Individuals

November 12th 2023

Richard Lazzaro, MD, FACS, discusses the advantages of standard low-dose computed tomography scans in lung cancer screening in high-risk individuals, as well as future opportunities to integrate biomarker-based assays into screening protocols to improve early detection.

Dr Haffty on Technical and Biological Advancements in Radiotherapy Within Breast Cancer

November 12th 2023

Bruce Haffty, MD, MS, discusses the significance of technical and biological advancements in approaches to radiotherapy, and how they engendered the de-escalation of radiotherapy for select patients with breast cancer.